Email us for help
Loading...
Premium support
Log Out
Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.
Fort Lauderdale, FL - Dr. Jan Lundberg, a distinguished leader in the bio-pharmaceutical industry with over four decades of experience, has embarked on a new venture as a pharmaceutical consultant. With a career that seamlessly bridged academia and industry, Lundberg is offering his wealth of expertise to drive innovation in drug discovery and development. Based in Fort Lauderdale, Florida, Lundberg is poised to provide strategic guidance to biotech firms, pharmaceutical companies, and academic institutions aiming to tackle the world’s most pressing health challenges.
Born in Sweden, Jan Lundberg’s journey in the sciences began during his studies in America with chemistry and psychology at Gustavus Adolphus College, Minnesota. His fascination with medicine had taken root at a young age, inspired by his uncle, who showed Jan his blood under a microscope. This early curiosity set him on a path through academia, medicine, and into the heart of pharmaceutical innovation.
Lundberg’s consulting services focus on key areas such as diabetes, Alzheimer’s disease, autoimmune disorders, and cancer. He is keenly aware of the complexities involved in treating conditions like cancer, which demands personalized approaches through precision medicine. “Cancer encompasses hundreds, if not thousands, of diseases. Tailored therapies based on individual biomarkers such as genetic profiles are the future,” asserts Lundberg.
After retiring from Eli Lilly, Lundberg enjoys the sun-drenched lifestyle of Fort Lauderdale, mixed with outdoor activities in Jackson Hole, Wyoming yet maintains strong professional connections with both Sweden and the global scientific community.
For more information about Jan Lundberg, please visit https://www.linkedin.com/in/jan-m-lundberg-77729a95/